Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 3 Neoplasms 2 Disease 2 Rectal Neoplasms 1 Pleural Effusion 1 Pleural Diseases 1 Pancreatitis, Chronic 1 Pancreatic carcinoma, familial 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Hereditary pancreatitis 1 Hematologic Diseases 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Carcinoma, Hepatocellular 1 Bone Marrow Diseases 1

Interventions

Echocardiography 14 Doxorubicin 10 Exercise 8 Electrocardiography 7 Trastuzumab 6 Cyclophosphamide 5 Carvedilol 5 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 dapagliflozin 2 Tablets 2 Social Determinants of Health 2 Silymarin 2 Magnetic Resonance Spectroscopy 2 Ivabradine 2 High-Intensity Interval Training 2 Exercise Test 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Bisoprolol 2 Antineoplastic Agents 2 Anthracyclines 2 sulforaphane 1 schizandrin 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 mitoquinone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cardiotoxicity × Clinical Laboratory Techniques × Clear all

NCT06664528 2025-03-04

CV_CANCER

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡